Investor Presentation for quarter ended 30th June, 2026

29th July, 2026 National Stock Exchange of India BSE Limited Limited Phiroze Jeejeebhoi Tower, Exchange Plaza, 5th Floor, Plot No. Dalal Street, C/1, Mumbai – 400 001 G-Block, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051 Trading Symbol: SHARDACROP Scrip Code: 538666 Subject: Investors / Analyst’s Presentation for the Quarter ended 30th June, 2026 Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we are enclosing herewith the presentation to be made to the Investors/Analysts on the Unaudited Financial Results of the Company for the quarter ended 30th June, 2026. The presentation is also being uploaded on the website of the Company www.shardacropchem.com in accordance with Regulation 46 of the Listing Regulations. We request you to take the same on record. Yours Sincerely, Jetkin Gudhka Company Secretary & Compliance Officer Encl.: As above STEADY. STRONG. GROWING. Investor Presentation July 2026 Safe Harbor This presentation has been prepared by and is the sole responsibility of Sharda Cropchem Limited (the “Company”). By accessing this presentation, you are agreeing to be bound by the trailing restrictions. This presentation does not constitute or form part of any offer or invitation or inducement to sell or issue, or any solicitation of any offer or recommendation to purchase or subscribe for, any securities of the Company, nor shall it or any part of it or the fact of its distribution form the basis of, or be relied on in connection with, any contract or commitment thereof. In particular, this presentation is not intended to be a prospectus or offer document under the applicable laws of any jurisdiction, including India. No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all events not current after the date of this presentation. There is no obligation to update, modify or amend this communication or to otherwise notify the recipient if the information, opinion, projection, forecast or estimate set forth herein, changes or subsequently becomes inaccurate. Certain statements contained in this presentation that are not statements of historical fact constitute “forward-looking statements.” You can generally identify forward looking statements by terminology such as “aim”, “anticipate”, “believe”, “continue”, “could”, “estimate”, “expect”, “intend”, “may”, “objective”, “goal”, “plan”, “potential”, “project”, “pursue”, “shall”, “should”, “will”, “would”, or other words or phrases of similar import. These forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors that may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements or other projections. Important factors that could cause actual results, performance or achievements to differ materially include, among others: (a) our ability to successfully implement our strategy, (b) our growth and expansion plans, (c) changes in regulatory norms applicable to the Company, (d) technological changes, (e) investment income, (f) cash flow projections, and (g) other risks. This presentation is for general information purposes only, without regard to any specific objectives, financial situations or informational needs of any particular person. The Company may alter, modify or otherwise change in any manner the content of this presentation, without obligation to notify any person of such change or changes. STEADY. STRONG. GROWING. ADVANCING GLOBAL AGRICULTURE THROUGH AN IP-LED GROWTH PLATFORM Sharda Cropchem Limited is a leading intellectual property-driven agrochemical company engaged in the marketing and distribution of crop protection formulations and generic active ingredients. Supported by a growing portfolio of dossiers, registrations and intellectual property rights, SCL has built a differentiated platform for sustainable growth across regulated global markets, particularly in Europe, North America, Latin America and Morocco. 3 CREATING VALUE At the core of SCL business model is a growing portfolio of regulatory assets that facilitates THROUGH AN access to some of the world’s most attractive crop protection markets. By partnering with specialized manufacturers for active ingredients, formulation and packaging, we remain capital ASSET-LIGHT, efficient, operationally agile and well positioned to scale across geographies and product categories REGISTRATION- SCL’s position within the value chain enables the Company to retain control over registrations LED BUSINESS and customer relationships while benefiting from the flexibility and efficiency of a partner-led manufacturing network MODEL SCL strategically participate in the stages where regulatory expertise, market knowledge and customer access create the greatest value, while leveraging specialized partners for manufacturing-related activities Basic & Active Product Product Formulation & Marketing & Applied Ingredient Identification Registration Packaging Distribution Research Manufacturing (Partner Led) (Partner Led) SCL’s Core Capabilities CREATING VALUE ACROSS THE CHAIN Identifying Building Regulatory Leveraging a Flexible Commercializing Opportunities Ahead Assets through Supply Network Products at Global of the Market Dossier Development Scale We source active ingredients through established supplier Continuously monitor patent Working with accredited Our products reach customers relationships, primarily from landscapes, crop trends and laboratories and technical through a network of more than China, ensuring supply regulatory developments to experts, we develop strong 525 distributors, supported by reliability, procurement identify generic molecules with dossiers aligned with a sales force of over 500 flexibility and cost strong commercial potential. By jurisdiction-specific professionals across key competitiveness initiating registrations ahead of requirements. These agricultural markets worldwide. market opportunities, SCL registrations serve as valuable This network also provides Value Created creates a foundation for future intellectual property assets and valuable market intelligence growth and market access create meaningful barriers to • Resilient supply chain that supports portfolio entry • Flexible procurement expansion and customer Value Created capabilities engagement • Early entry into attractive Value Created • Efficient cost structure product categories • Long-term market access • Responsive sourcing Value Created capabilities • Diversified product • Strong competitive • Global market reach portfolio differentiation • Diversified revenue streams • Long-term revenue visibility • High entry barriers • Faster commercialization • Sustainable growth • Scalable registration • Strong customer opportunities portfolio relationships ENSURING REACH THAT SERVES GLOBALLY Countries SCL’s extensive global presence is complemented by a well-established 525+ network of third-party distributors. Supported by a network of Together, these capabilities enable distributors and sales Distributors the effective commercialisation of formulations and generic active professionals, SCL serves ingredients while strengthening customers across 80+ countries 500+ customer engagement. spanning Europe, North America, Sales Professionals SCL’s global footprint supports a Latin America, Africa, and other factory-to-farmer approach, Rs. 263 Crs. broadens revenue streams and international markets. This enhances business resilience. extensive presence not only Capex (Q1 FY27) Combined with local market expertise and strong channel partnerships, it expands the Company’s market provides a s [Showing first 8,000 characters — download PDF for full document]